FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AAUAFALMADEN MINERALS LTD

Inspect →

AAUCAllied Gold Corp

Inspect →

AAWHAscend Wellness Holdings, Inc.

Inspect →

ABALLIANCEBERNSTEIN HOLDING L.P.

Inspect →

ABATAMERICAN BATTERY TECHNOLOGY Co

Inspect →

ABBVAbbVie Inc.

Inspect →

ABCBAmeris Bancorp

Inspect →

ABCFFABACUS MINING & EXPLORATION CORP

Inspect →

ABCLAbCellera Biologics Inc.

Inspect →

ABCPAmBase Corp

Inspect →

ABEOABEONA THERAPEUTICS INC.

Inspect →

ABEVAMBEV S.A.

Inspect →

03 / FINANCIAL CHANGES

Coherus Oncology, Inc. CHRS

Biological Products, (No Diagnostic Substances) · SIC 2836

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-09 · Retrieved: 2026-11-11

Compared with the same period of the prior year, ending 2025-09-30.

Revenue14.27

USD million

Change year over year: +2.70 · +23.4%

Net income-39.33

USD million

Change year over year: -3.80

Operating cash flow-34.02

USD million

Change year over year: +12.32

Total liabilities145.86

USD million

Change year over year: -282.89

Total assets171.10

USD million

Change year over year: -345.42

Liabilities / assets: 85.2% · Change: +2.2 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-03-09 · Retrieved: 2026-11-11

Compared with the same period of the prior year, ending 2024-12-31.

Revenue42.17

USD million

Change year over year: -224.79 · -84.2%

Net income168.02

USD million

Change year over year: +139.52

Operating cash flow-138.51

USD million

Change year over year: -118.07

Total liabilities197.33

USD million

Change year over year: -383.19

Total assets258.34

USD million

Change year over year: -190.19

Liabilities / assets: 76.4% · Change: -53.0 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
PALI ↗	2025-12-31	0.00	—	—
IBRX ↗	2025-12-31	113.29	-310.2%	-269.2%
PLX ↗	2025-12-31	52.74	-12.5%	-22.7%
CGON ↗	2025-12-31	4.04	-3,985.0%	-3,275.9%
MAZE ↗	2025-12-31	—	—	—
SABS ↗	2025-12-31	0.00	—	—

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

AMBQ ↗

Ambiq Micro, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

PAYS ↗

Paysign, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

LAND ↗

GLADSTONE LAND Corp

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

AMBO ↗

Ambow Education Holding Ltd.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

ELMD ↗

Electromed, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

ABUS ↗

Arbutus Biopharma Corp

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

MRDN ↗

Meridian Holdings Inc./NV

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

KURA ↗

Kura Oncology, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

IBIO ↗

iBio, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

SNWV ↗

SANUWAVE Health, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

BNGO ↗

Bionano Genomics, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

GEVO ↗

Gevo, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →